Organization
Orexo has broad-based competence throughout the development chain from early preclinical research and development, formulation and clinical development to the registration of drugs and industrial-scale production. Orexo collaborates with consultants and contract research organisations for certain aspects, such as clinical trials.
Orexo has a largely project-led organization, for which skills are combined on the basis of the specific demands in individual projects. The continual development of the organization is a prerequisite for conducting more projects in parallel and in different phases of development. Orexo has its own production facility which is approved by the Swedish Medical Products Agency and which also meets international quality requirements (cGMP).
Orexo has 108 employees in Uppsala and in Bath, UK.